RWJ 63556 is an orally activeCOX-2selective/5-lipoxygenaseinhibitor, with anti-inflammatory activities.

RWJ 63556 is a potent inhibitor of leukocyte influx over a period of 24 hr and maintains its in vitro profile on eicosanoids^[1].

RWJ 63556 (1 mg/kg, i.v.) significantly inhibits the development of SP-induced oedema^[2].

287.33

C₁₁H₁₀FNO₃S₂

190967-35-2

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.